Melanoma: all 3,073 studies

Page 31 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.

• Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005815Phase 1/2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00005633Phase 1
• Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant MelanomaCompletedNCT00005617Phase 1
• Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-AlfaCompletedNCT00005615Phase 1/2
• Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the LungCompletedNCT00005610Phase 2
• Gene Therapy and Ganciclovir in Treating Patients With Stage IV MelanomaCompletedNCT00005057Phase 1
• Vaccine Therapy in Treating Patients With Primary Stage II MelanomaStatus unknownNCT00005052Phase 3
• Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By SurgeryCompletedNCT00004250Phase 2
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant MelanomaCompletedNCT00004244Phase 1
• Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node MetastasisCompletedNCT00004196Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00004184Phase 1/2
• Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With MelanomaCompletedNCT00004153Not applicable
• PET and CT Scans to Evaluate Patients With Stage III or Stage IV MelanomaCompletedNCT00004152Phase 2
• Vaccine Therapy in Treating Patients With Unresectable Metastatic MelanomaCompletedNCT00004148Phase 1
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00004141Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerCompletedNCT00004135Phase 2
• Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III MelanomaCompletedNCT00004104Phase 2
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00004025Phase 1/2
• Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00004022Phase 2
• Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid TumorsCompletedNCT00004016Phase 1
• ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaCompletedNCT00003989Phase 2
• S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain MetastasesTerminatedNCT00003911Phase 2
• Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant MelanomaCompletedNCT00003897Phase 1
• S9804: Vinorelbine in Treating Patients With Stage IV MelanomaCompletedNCT00003828Phase 2
• Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaCompletedNCT00003802Phase 2
• Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00003792Phase 1
• Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegCompletedNCT00003789Phase 3
• Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other TumorsCompletedNCT00003750Phase 1
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic MelanomaStatus unknownNCT00003747Phase 1
• Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III MelanomaTerminatedNCT00003715Phase 2
• Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003690Phase 1
• Vaccine Therapy in Treating Patients With Stage IV MelanomaCompletedNCT00003665Phase 1
• Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003647Phase 3
• Gene Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003646Phase 2
• Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus SyndromeCompletedNCT00003601Phase 2
• Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00003568Phase 2
• Vaccine Therapy in Treating Patients With MelanomaCompletedNCT00003556Phase 1
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic MelanomaTerminatedNCT00003552Phase 1/2
• Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the GroinCompletedNCT00003444Phase 3
• Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced MelanomaCompletedNCT00003362Phase 2
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003346Phase 2
• Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00003339Phase 2
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by SurgeryCompletedNCT00003274Phase 2
• Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor RemovalCompletedNCT00003229Phase 1/2
• High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaCompletedNCT00003091Phase 2
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic MelanomaTerminatedNCT00003060Phase 1
• Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00003027Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerCompletedNCT00003022Phase 1
• Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced MelanomaCompletedNCT00002973Phase 2
• Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic MelanomaCompletedNCT00002952Phase 1/2
• Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1
• Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent MelanomaCompletedNCT00002892Phase 3
• Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With MelanomaCompletedNCT00002882Phase 3
• SWOG-9430: Surgery in Treating Patients With Metastatic MelanomaCompletedNCT00002860Phase 2
• Interleukin-2 in Treating Patients With Metastatic MelanomaStatus unknownNCT00002845Phase 2
• Vaccine Therapy in Treating Patients With Metastatic MelanomaStatus unknownNCT00002817Phase 1/2
• Biological Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00002786Phase 1/2
• Boron Neutron Capture Therapy in Treating Patients With Stage III MelanomaStatus unknownNCT00002781Phase 1
• Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic MelanomaStatus unknownNCT00002767Phase 3
• High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III MelanomaStatus unknownNCT00002763Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsCompletedNCT00002754Phase 1
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00002733Phase 2
• Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNCT00002669Phase 2
• Indomethacin Plus Biological Therapy in Treating Patients With Advanced MelanomaCompletedNCT00002535Phase 2
• Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or MelanomaStatus unknownNCT00002455Phase 3
• Microarray Analysis for Human Genetic DiseaseCompletedNCT00001898
• Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal SequenceCompletedNCT00001705Phase 2
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the ExtremityCompletedNCT00001577Phase 1
• A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's AdjuvantCompletedNCT00001439Phase 1
• A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity MelanomaCompletedNCT00001296Phase 3

← Melanoma overview